Requirement of the MADS-box transcription factor MEF2C for vascular development.

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest (2000) 3.70

The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci U S A (2003) 3.40

GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J (2000) 2.79

Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol Cell Biol (2002) 2.78

Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest (2004) 2.76

Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell (2008) 2.60

Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A (2000) 2.30

The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest (2008) 2.24

Transcriptional control of endothelial cell development. Dev Cell (2009) 2.12

Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl Acad Sci U S A (2002) 2.11

ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol Cell Biol (2000) 2.02

Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol Cell Biol (2007) 1.79

Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. J Biol Chem (2008) 1.78

The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell (2006) 1.76

Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circ Res (2013) 1.68

Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol Cell Biol (2006) 1.55

Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat Immunol (2008) 1.51

Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c. Nat Immunol (2009) 1.49

Transcriptional pathways in second heart field development. Semin Cell Dev Biol (2007) 1.43

TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J (2004) 1.42

The transcription factor MEF2C is required for craniofacial development. Dev Cell (2007) 1.40

p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol (2002) 1.38

Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase. Mol Cell Biol (2005) 1.38

mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish. Dev Biol (2007) 1.30

Genetic framework for GATA factor function in vascular biology. Proc Natl Acad Sci U S A (2011) 1.29

Cardiovascular development and the colonizing cardiac neural crest lineage. ScientificWorldJournal (2007) 1.26

The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J Clin Invest (2000) 1.21

A p38 MAPK-MEF2C pathway regulates B-cell proliferation. Proc Natl Acad Sci U S A (2008) 1.19

HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol Cell Biol (2004) 1.18

The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost (2009) 1.18

Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol Cell Biol (2008) 1.18

ETS factors regulate Vegf-dependent arterial specification. Dev Cell (2013) 1.16

Rapid recruitment of temporally distinct vascular gene sets by estrogen. Mol Endocrinol (2008) 1.16

Lost in transgenesis: a user's guide for genetically manipulating the mouse in cardiac research. Circ Res (2012) 1.14

Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Mol Cell Biol (2004) 1.14

Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. J Mol Cell Cardiol (2010) 1.12

Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem (2006) 1.10

Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J Biol Chem (2009) 1.08

Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am J Physiol Heart Circ Physiol (2009) 1.07

Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells. Invest Ophthalmol Vis Sci (2008) 1.06

Myocardin in biology and disease. J Biomed Res (2014) 1.06

Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differentiation. Dev Biol (2012) 0.98

FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms. J Biol Chem (2010) 0.98

MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Am J Pathol (2012) 0.98

A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression. J Biol Chem (2012) 0.96

Distinct effects of voltage- and store-dependent calcium influx on stretch-induced differentiation and growth in vascular smooth muscle. J Biol Chem (2010) 0.94

MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C. Sci Rep (2015) 0.93

Long-range enhancers modulate Foxf1 transcription in blood vessels of pulmonary vascular network. Histochem Cell Biol (2016) 0.93

Cardiac outflow tract anomalies. Wiley Interdiscip Rev Dev Biol (2013) 0.92

Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis. BMC Cancer (2015) 0.92

The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10. Development (2011) 0.92

Myocyte enhancer factor 2A is transcriptionally autoregulated. J Biol Chem (2007) 0.92

Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling. Oncogene (2014) 0.90

Myocyte enhancer factor 2 and chorion factor 2 collaborate in activation of the myogenic program in Drosophila. Mol Cell Biol (2007) 0.90

Undermining the endothelium by ablation of MAPK-MEF2 signaling. J Clin Invest (2004) 0.90

Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling. Nucleic Acids Res (2014) 0.90

Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. Angiogenesis (2008) 0.89

VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C. PLoS One (2011) 0.88

Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes. Development (2015) 0.88

The short and long of noncoding sequences in the control of vascular cell phenotypes. Cell Mol Life Sci (2015) 0.88

Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc. FASEB J (2009) 0.88

Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood (2009) 0.88

Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Funct Integr Genomics (2005) 0.87

Endothelium as master regulator of organ development and growth. Vascul Pharmacol (2008) 0.86

Tbx1 is a negative modulator of Mef2c. Hum Mol Genet (2012) 0.84

Direct evidence for pitavastatin induced chromatin structure change in the KLF4 gene in endothelial cells. PLoS One (2014) 0.84

Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2. Circ Res (2016) 0.83

Hemodynamic forces regulate embryonic stem cell commitment to vascular progenitors. Curr Cardiol Rev (2008) 0.83

Calcineurin initiates smooth muscle differentiation in neural crest stem cells. J Cell Biol (2004) 0.82

Small leucine zipper protein (sLZIP) negatively regulates skeletal muscle differentiation via interaction with α-actinin-4. J Biol Chem (2013) 0.82

Vertebrate paralogous MEF2 genes: origin, conservation, and evolution. PLoS One (2011) 0.82

Protein kinase D1, a new molecular player in VEGF signaling and angiogenesis. Mol Cells (2009) 0.82

Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nat Genet (2017) 0.81

MEF2C and EBF1 Co-regulate B Cell-Specific Transcription. PLoS Genet (2016) 0.81

Characterization of Pax3-expressing cells from adult blood vessels. J Cell Sci (2011) 0.81

Combinatorial transcriptional interaction within the cardiac neural crest: a pair of HANDs in heart formation. Birth Defects Res C Embryo Today (2004) 0.81

MEF2 transcription factors: developmental regulators and emerging cancer genes. Oncotarget (2016) 0.81

Mef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene. J Cell Mol Med (2007) 0.80

Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. PLoS One (2013) 0.80

A p38 Mitogen-Activated Protein Kinase-Regulated Myocyte Enhancer Factor 2-β-Catenin Interaction Enhances Canonical Wnt Signaling. Mol Cell Biol (2015) 0.80

Mef2d acts upstream of muscle identity genes and couples lateral myogenesis to dermomyotome formation in Xenopus laevis. PLoS One (2012) 0.79

Functional gene expression analysis of tissue-specific isoforms of Mef2c. Cell Mol Neurobiol (2011) 0.79

Comparative analysis reveals distinct and overlapping functions of Mef2c and Mef2d during cardiogenesis in Xenopus laevis. PLoS One (2014) 0.79

Promotion of avian endothelial cell differentiation by GATA transcription factors. Dev Biol (2011) 0.79

MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension. PLoS One (2016) 0.78

Transcription factor MEF2C suppresses endothelial cell inflammation via regulation of NF-κB and KLF2. J Cell Physiol (2015) 0.78

MEF2 transcription factors are key regulators of sprouting angiogenesis. Genes Dev (2016) 0.78

Endothelin signaling activates Mef2c expression in the neural crest through a MEF2C-dependent positive-feedback transcriptional pathway. Development (2015) 0.77

The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming. J Cardiovasc Dev Dis (2016) 0.76

Endothelial Aquaporin-1 (AQP1) Expression Is Regulated by Transcription Factor Mef2c. Mol Cells (2016) 0.76

Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers. Cell Death Discov (2015) 0.75

Protein expression of MEF2C during the critical period for visual development in vervet monkeys. Mcgill J Med (2008) 0.75

Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements. J Pediatr Genet (2017) 0.75

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66

Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol (2001) 10.32

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell (1999) 9.84

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature (2000) 8.59

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell (2001) 8.09

Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol (2001) 7.97

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med (1999) 7.56

Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 7.31

Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol (2003) 6.99

Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75

Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev (1997) 6.52

Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell (1995) 6.24

Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res (2000) 6.20

Missing lithotroph identified as new planctomycete. Nature (1999) 6.17

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01

A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev (1989) 5.91

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science (1997) 5.54

Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell (1999) 5.52

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med (1994) 5.46

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14

Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell (2000) 5.13

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev (1998) 4.86

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell (1990) 4.84

A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol (1989) 4.72

Simulation of Sahel drought in the 20th and 21st centuries. Proc Natl Acad Sci U S A (2005) 4.70

Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57

Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A (2000) 4.27

Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A (2000) 4.08

PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A (1993) 4.05

Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell (1994) 3.95

Smad3 mutant mice develop metastatic colorectal cancer. Cell (1998) 3.92

Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet (1997) 3.89

The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87

HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J (1999) 3.80

Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. Genome Res (1998) 3.80

Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest (2000) 3.70

Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell (1994) 3.66

Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science (1995) 3.64

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res (1996) 3.60

MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature (1999) 3.54

Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development (1994) 3.53

The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci (2002) 3.52

A genetic blueprint for cardiac development. Nature (2000) 3.45

Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell (2000) 3.39

Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24

Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol Cell Biol (1988) 3.24

Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem (2000) 3.19

Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev (1990) 3.18

Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev (2001) 3.17

Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet (1994) 3.17

Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet (1989) 3.12

PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron (1998) 3.09

Acylation of proteins with myristic acid occurs cotranslationally. Science (1987) 3.08

PATRIC: the VBI PathoSystems Resource Integration Center. Nucleic Acids Res (2006) 3.06

Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res (2000) 3.04

Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol (1999) 3.02

SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res (1996) 2.96

Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development (1998) 2.92

Microsomal triglyceride transfer protein expression during mouse development. J Lipid Res (2000) 2.90

Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol (1986) 2.90

Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol (1996) 2.88

Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med (2000) 2.79

Melanopsin in cells of origin of the retinohypothalamic tract. Nat Neurosci (2001) 2.79

Defining the regulatory networks for muscle development. Curr Opin Genet Dev (1996) 2.79

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob Agents Chemother (2006) 2.75

HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol (1992) 2.72

Human homologues of yeast helicase. Nature (1996) 2.71

Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res (2001) 2.67

Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol Cell Biol (1992) 2.64

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64

Specificity of fatty acid acylation of cellular proteins. J Biol Chem (1985) 2.63

The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol (1991) 2.63

Effects of legal termination on subsequent pregnancy. Br Med J (1976) 2.59

Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem (2000) 2.59

The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58

Nitriding iron at lower temperatures. Science (2003) 2.55

Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A (1993) 2.53

A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res (1999) 2.49

Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development (1998) 2.49

A new semisynthetic 7alpha-methoxycephalosporin, CS-1170: 7beta-((cyanomethyl)thio)acetamido)-7alpha-methoxy-3-((1-methyl-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid. J Antibiot (Tokyo) (1976) 2.48

Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod (1994) 2.48

Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem (2001) 2.45

Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol (1991) 2.40

Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol (1996) 2.40

Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science (1998) 2.39

A subclass of bHLH proteins required for cardiac morphogenesis. Science (1995) 2.39

Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38

Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res (1994) 2.37